531 related articles for article (PubMed ID: 23782457)
1. Development and validation of a prognostic model to predict death in patients with traumatic bleeding, and evaluation of the effect of tranexamic acid on mortality according to baseline risk: a secondary analysis of a randomised controlled trial.
Perel P; Prieto-Merino D; Shakur H; Roberts I
Health Technol Assess; 2013 Jun; 17(24):1-45, v-vi. PubMed ID: 23782457
[TBL] [Abstract][Full Text] [Related]
2. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients.
Roberts I; Shakur H; Coats T; Hunt B; Balogun E; Barnetson L; Cook L; Kawahara T; Perel P; Prieto-Merino D; Ramos M; Cairns J; Guerriero C
Health Technol Assess; 2013 Mar; 17(10):1-79. PubMed ID: 23477634
[TBL] [Abstract][Full Text] [Related]
3. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial.
Roberts I; Perel P; Prieto-Merino D; Shakur H; Coats T; Hunt BJ; Lecky F; Brohi K; Willett K;
BMJ; 2012 Sep; 345():e5839. PubMed ID: 22968527
[TBL] [Abstract][Full Text] [Related]
4. Predicting early death in patients with traumatic bleeding: development and validation of prognostic model.
Perel P; Prieto-Merino D; Shakur H; Clayton T; Lecky F; Bouamra O; Russell R; Faulkner M; Steyerberg EW; Roberts I
BMJ; 2012 Aug; 345():e5166. PubMed ID: 22896030
[TBL] [Abstract][Full Text] [Related]
5. CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) intracranial bleeding study: the effect of tranexamic acid in traumatic brain injury--a nested randomised, placebo-controlled trial.
Perel P; Al-Shahi Salman R; Kawahara T; Morris Z; Prieto-Merino D; Roberts I; Sandercock P; Shakur H; Wardlaw J
Health Technol Assess; 2012; 16(13):iii-xii, 1-54. PubMed ID: 22417901
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid to reduce head injury death in people with traumatic brain injury: the CRASH-3 international RCT.
Roberts I; Shakur-Still H; Aeron-Thomas A; Beaumont D; Belli A; Brenner A; Cargill M; Chaudhri R; Douglas N; Frimley L; Gilliam C; Geer A; Jamal Z; Jooma R; Mansukhani R; Miners A; Pott J; Prowse D; Shokunbi T; Williams J
Health Technol Assess; 2021 Apr; 25(26):1-76. PubMed ID: 33928903
[TBL] [Abstract][Full Text] [Related]
7. Antifibrinolytic drugs for acute traumatic injury.
Ker K; Roberts I; Shakur H; Coats TJ
Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
[TBL] [Abstract][Full Text] [Related]
8. Use of tranexamic acid in major trauma: a sex-disaggregated analysis of the Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage (CRASH-2 and CRASH-3) trials and UK trauma registry (Trauma and Audit Research Network) data.
Nutbeam T; Roberts I; Weekes L; Shakur-Still H; Brenner A; Ageron FX
Br J Anaesth; 2022 Aug; 129(2):191-199. PubMed ID: 35597623
[TBL] [Abstract][Full Text] [Related]
9. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
; Roberts I; Shakur H; Afolabi A; Brohi K; Coats T; Dewan Y; Gando S; Guyatt G; Hunt BJ; Morales C; Perel P; Prieto-Merino D; Woolley T
Lancet; 2011 Mar; 377(9771):1096-101, 1101.e1-2. PubMed ID: 21439633
[TBL] [Abstract][Full Text] [Related]
10. A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCT.
Roberts I; Shakur-Still H; Afolabi A; Akere A; Arribas M; Austin E; Bal K; Bazeer N; Beaumont D; Brenner A; Carrington L; Chaudhri R; Coats T; Gilmore I; Halligan K; Hussain I; Jairath V; Javaid K; Kayani A; Lisman T; Mansukhani R; Miners A; Mutti M; Nadeem MA; Pollok R; Prowse D; Simmons J; Stanworth S; Veitch A; Williams J
Health Technol Assess; 2021 Oct; 25(58):1-86. PubMed ID: 34663491
[TBL] [Abstract][Full Text] [Related]
11. Effect of tranexamic acid on intracranial haemorrhage and infarction in patients with traumatic brain injury: a pre-planned substudy in a sample of CRASH-3 trial patients.
Mahmood A; Needham K; Shakur-Still H; Harris T; Jamaluddin SF; Davies D; Belli A; Mohamed FL; Leech C; Lotfi HM; Moss P; Lecky F; Hopkins P; Wong D; Boyle A; Wilson M; Darwent M; Roberts I
Emerg Med J; 2021 Apr; 38(4):270-278. PubMed ID: 33262252
[TBL] [Abstract][Full Text] [Related]
12. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
; Shakur H; Roberts I; Bautista R; Caballero J; Coats T; Dewan Y; El-Sayed H; Gogichaishvili T; Gupta S; Herrera J; Hunt B; Iribhogbe P; Izurieta M; Khamis H; Komolafe E; Marrero MA; Mejía-Mantilla J; Miranda J; Morales C; Olaomi O; Olldashi F; Perel P; Peto R; Ramana PV; Ravi RR; Yutthakasemsunt S
Lancet; 2010 Jul; 376(9734):23-32. PubMed ID: 20554319
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
[TBL] [Abstract][Full Text] [Related]
14. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial.
Williams-Johnson JA; McDonald AH; Strachan GG; Williams EW
West Indian Med J; 2010 Dec; 59(6):612-24. PubMed ID: 21702233
[TBL] [Abstract][Full Text] [Related]
15. Tranexamic acid in bleeding trauma patients: an exploration of benefits and harms.
Roberts I; Edwards P; Prieto D; Joshi M; Mahmood A; Ker K; Shakur H
Trials; 2017 Jan; 18(1):48. PubMed ID: 28143564
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial.
Roberts I; Prieto-Merino D; Manno D
Crit Care; 2014 Dec; 18(6):685. PubMed ID: 25498484
[TBL] [Abstract][Full Text] [Related]
17. Understanding the neuroprotective effect of tranexamic acid: an exploratory analysis of the CRASH-3 randomised trial.
Brenner A; Belli A; Chaudhri R; Coats T; Frimley L; Jamaluddin SF; Jooma R; Mansukhani R; Sandercock P; Shakur-Still H; Shokunbi T; Roberts I;
Crit Care; 2020 Nov; 24(1):560. PubMed ID: 33172504
[TBL] [Abstract][Full Text] [Related]
18. Avoidable mortality from giving tranexamic acid to bleeding trauma patients: an estimation based on WHO mortality data, a systematic literature review and data from the CRASH-2 trial.
Ker K; Kiriya J; Perel P; Edwards P; Shakur H; Roberts I
BMC Emerg Med; 2012 Mar; 12():3. PubMed ID: 22380715
[TBL] [Abstract][Full Text] [Related]
19. Severely injured trauma patients with admission hyperfibrinolysis: Is there a role of tranexamic acid? Findings from the PROPPR trial.
Khan M; Jehan F; Bulger EM; OʼKeeffe T; Holcomb JB; Wade CE; Schreiber MA; Joseph B;
J Trauma Acute Care Surg; 2018 Nov; 85(5):851-857. PubMed ID: 29985230
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid in trauma: how should we use it?
Roberts I
J Thromb Haemost; 2015 Jun; 13 Suppl 1():S195-9. PubMed ID: 26149023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
